Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Disease: Primary Aggregated Analysis of All Baskets from the Phase II Randomized EXTEND Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
Journal: European urology
Published: September 12, 2025
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial.
Journal: The Lancet. Oncology
Published: April 28, 2025
Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.
Journal: European urology
Published: April 23, 2025
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic Prostate Cancer: The EXTEND Phase 2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: April 06, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract.
Journal: European urology oncology
Published: March 20, 2023
Erratum to "Periorbital edema associated with alpelisib" [Cancer Treatment and Research Communications 32 (2022) 100596].
Journal: Cancer treatment and research communications
Published: December 03, 2022
Periorbital edema associated with alpelisib.
Journal: Cancer treatment and research communications
Published: May 04, 2022
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: August 15, 2019
Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report.
Journal: Journal of medical case reports
Published: September 03, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026